Finance News – 23Andme
What is your interest today?
- ABC News Business
- BBC Business
- Business Insider Markets
- CBC Business
- City A.M.
- CNBC Business
- CoinDesk
- Cointelegraph
- Crypto News
- CryptoSlate
- Decrypt
- Economic Times Markets
- Euronews Business
- Financial Post Top Stories
- Financial Times
- Finextra Crypto
- Finextra Market
- Finextra Wealth
- Globe and Mail Investing
- Investing.com Global Markets
- Investing.com Global Mkts
- Investopedia
- Kiplinger
- MarketWatch MarketPulse
- MarketWatch Top Stories
- Quartz
- Sky News Money
- Sydney Morning Herald Biz
- Sydney Morning Herald Business
- TechCrunch Fintech
- The Block
- The Guardian – Business
- WSJ Markets News
DNA testing firm 23andMe fined £2.3m by UK regulator for 2023 data hack
The £2.3 million penalty imposed on 23andMe highlights the financial repercussions companies face for inadequate cybersecurity measures resulting in unauthorized access to sensitiv...
Read Full Article →Dozens of states want to block 23andMe from selling DNA info
Multiple states and the District of Columbia have initiated legal action to prevent a genetic testing company from profiting by distributing users’ sensitive genetic data without e...
Read Full Article →23andMe back on the auction block after former CEO makes 11th-hour bid
The recent $305 million offer from a principal insider disrupted a prior $256 million purchase deal, potentially altering the financial outcome of the company’s bankruptcy asset sa...
Read Full Article →23andMe to delist from Nasdaq, deregister with SEC
The planned acquisition of most 23andMe assets by Regeneron Pharmaceuticals for $256 million will result in the company's withdrawal from public stock trading and regulatory report...
Read Full Article →Bankrupt DNA testing firm 23andMe to be purchased for $256m
Regeneron Pharmaceuticals’ acquisition of a consumer genetic testing company for $256 million during bankruptcy highlights a significant investment in genetic data assets, promptin...
Read Full Article →Struggling DNA testing firm 23andMe to be bought for $256m
The acquisition of 23andMe by Regeneron for $256 million highlights a notable investment in the genetic testing industry while ensuring continued commitment to safeguarding consume...
Read Full Article →